AgeneBio

company

About

AgeneBio is a neuroscience pharmaceutical company developing treatments for diseases that impact memory.

  • 1 - 10

Details

Last Funding Type
Grant
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2008
Number Of Employee
1 - 10
Operating Status
Active

AgeneBio is a neuroscience pharmaceutical company founded by Dr Michela Gallagher in 2008 that is focused on developing treatments for diseases that impact memory. The initial therapeutic targets are Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer's disease (AD). The company is headquartered in Indianapolis but conducts research and development work on a global basis utilizing partner relationships.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$3.40M
AgeneBio has raised a total of $3.40M in funding over 2 rounds. Their latest funding was raised on Sep 13, 2019 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 13, 2019 Grant $3.40M 1 National Institutes of Health Detail
Oct 11, 2018 Grant 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
2
1
AgeneBio is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant